ClinicalTrials.Veeva

Menu

Development and Validation of a Predictive Score for Surgical Site Infections (SPRED)

H

Hopital Foch

Status

Completed

Conditions

Colon or Colorectal Resection
Hepatectomy
Partial or Total Gastrectomy
Pancreaticoduodenectomy

Treatments

Biological: Peripheral venous blood samples

Study type

Interventional

Funder types

Other

Identifiers

NCT05523713
2022-A01012-41

Details and patient eligibility

About

More than 8 millions surgical interventions are carried out each year in France. Postoperative complications, in particular infectious, can occur in 10 to 60% of cases and are the cause of postoperative revision in 30% of cases, an increase in mortality, length of stay, readmissions and lead to significant additional socio-economic costs. Currently, improvements in surgical practices have not reduced the incidence of surgical site complications. In this context, the development of predictive scores for the risk of post-operative complication becomes urgent in order to implement new interventions (pre-habilitation) or to modify surgical decisions (timing, approach) in order to reduce the risk of complications before surgery. Several recent studies highlights the importance of the immune response in postoperative prognosis. In particular, an imbalance between the adaptive and innate response involving MDSCs has been demonstrated in patients with postoperative complications.Thanks to new techniques for analyzing the immune system, in-depth analysis of the immune system before surgery is a very promising approach aimed at identifying predictive biomarkers of postoperative prognosis.

Our team has developed and patented a multivariate model integrating mass cytometry data, proteomics and clinical data collected before surgery to accurately predict the occurrence of a surgical site complication (AUC = 0.94, p<10e-7) in a monocentric cohort of 43 patients to major abdominal surgery (Stanford University).

The objective of the present study is to generalize and validate this preoperative predictive score of infectious complications of the surgical site in the 30 days following major digestive surgery on a larger workforce within a multicenter cohort and to validate this score at using a machine learning method.

Full description

Research hypothesis and expected impact:

Postoperative complications are frequent and associated with excess mortality and increased costs for the health system. But, it is possible to avoid a significant number of these complications through prehabilitation programs, in particular to prepare patients at risk, and to reduce these postoperative events by 30%. However, it is currently not possible to predict, before surgery, which patients are at risk of developing a complication. Current predictive clinical scores such as the one developed by the American College of Surgeons are unsatisfactory (AUC = 68%).

This study will be a reference study to define the groups of patients at risk of complications in order to develop, in a second step, personalized patient pathways in order to optimize their health before surgery and thus improve post-operative results.

Enrollment

283 patients

Sex

All

Ages

18 to 99 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Patients will be included:

  • Aged 18 and over
  • Having undergone elective major digestive surgery:

Major surgery defined according to the recent recommendations of the European Surgical Association - PMID: 32172309 by a rate of infectious or cognitive complications between 20 and 30% according to the ACS risk calculator

  • Having expressed their non-opposition to participate in the study
  • Being affiliated to a French health insurance

Exclusion criteria

Patients with the following criteria will not be included:

  • Aged under 18
  • Having an ASA 4 or more, in palliative care
  • Having an expected duration of hospitalization < 24 hours
  • Not speaking French, illiterate patient
  • Having expressed their opposition to participate in the study
  • Current pregnancy or breastfeeding
  • Absence of affiliation to social security plan
  • Being deprived of liberty or under guardianship

Trial design

Primary purpose

Other

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

283 participants in 1 patient group

Patients with major elective digestive surgery
Other group
Description:
The size of the cohort is 300 patients Population: Patients with major elective digestive surgery (eg, colon or colorectal resection, partial or total gastrectomy, pancreaticoduodenectomy, hepatectomy).
Treatment:
Biological: Peripheral venous blood samples

Trial contacts and locations

4

Loading...

Central trial contact

Morgan LE GUEN; FRANCK VERDONK

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems